Drug & intervention

mirabegron

RxCUI 1300786

Clinical trials10
Recruiting1
Related conditions15
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

10 shown
Mechanisms for Activation of Beige Adipose Tissue in HumansNCT04666636 · 2020-12-07
RECRUITING
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With ObesityNCT05713799 · 2026-10-12
NOT_YET_RECRUITING
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson DiseaseNCT07187466 · 2026-10-01
NOT_YET_RECRUITING
ADRB3 Signaling Pathway in Human Adipose TissueNCT05634174 · 2023-08-01
ACTIVE_NOT_RECRUITING
Activation of Brown Adipose Tissue Metabolism Using MirabegronNCT04823442 · 2021-01-21
COMPLETED
Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized StudyNCT03600766 · 2018-08-01
UNKNOWN
Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's DiseaseNCT03412513 · 2017-07-17
UNKNOWN
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor AgonistsNCT03049462 · 2017-03-13
COMPLETED
Mirabegron in Parkinson Disease and Impaired CognitionNCT02536976 · 2015-12-01
COMPLETED
A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO)NCT02092181 · 2014-03-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.